Remarkably, we found that MASTL vulnerability in thyroid tumor cell lines is not associated with overexpression; on the contrary, MASTL is slightly downregulated in PTC samples and in thyroid tumor cells. The gene discussed is MASTL; the disease is thyroid tumor.